Abstract:BACKGROUND:Non-invasive prenatal testing (NIPT) as alternative screening method had been proven to have very high sensitivity and specificity for detecting common aneuploidies such as T21, T18, and T13, with low false positive and false negative rates. Unfortunately, recent studies suggested that the NIPT achieved lower accuracy in sex chromosomal aneuploidies (SCAs) detection than autosomal aneuploidies detection. BGISEQ-500 powered by Combinatorial Probe-Anchor Synthesis (CPAS) and DNA Nanoballs (DNBs) technology that combined linear amplification and rolling circle replication to reduce the error rate while enhancing the signal. Therefore, NIPT based on CPAS might be a good method for SCAs screening in routine clinical practice. In the study, we intended to evaluate the clinical utility of NIPT based on CPAS on screening for fetal SCAs.RESULTS:A total of 570 pregnant women were included in the retrospective study. Maternal blood samples were collected for NIPT; amniocentesis was performed on all pregnant women. NIPT was carried out by BGISEQ-500 sequencing platform based on CPAS. Karyotype analysis of amniotic cells was performed by standard G-banding techniques. 43 out of the total 570 pregnant women tested by NIPT showed fetal SCAs (19 of 45,X, 12 of 47,XXY, 10 of 47,XXX, and 2 of 47,XYY). The following amniocentesis confirmed that 26 cases were true positive (7 of true positive 45,X, 9 of true positive 47,XXY, 9 of true positive 47,XXX as well as 1 of 47,XYY) and the positive predictive value (PPV) for fetal SCAs was 60.47%. In addition, the PPV of advanced maternal age group (67.74%) was higher than the other indications group (45.45%) or serological screening high-risk /critical-risk group (0%).CONCLUSIONS:NIPT based on CPAS could be a potential method for SCAs screening. However, it still had high false positive rates, especially for 45,X. The pregnant women with fetal SCAs detected by NIPT, especially those with non-age-related prenatal diagnostic indications, should be advised to accept invasive prenatal karyotype analysis.

Study on rapid genetic diagnosis of trisomy 21

Predictive Significance of Risk Value in Prenatal Screening for Fetal Trisomy 18

Clinical application of noninvasive prenatal testing for the detection of trisomies 21, 18, and 13: a hospital experience.

Noninvasive Prenatal Testing of Trisomies 21 and 18 by Massively Parallel Sequencing of Maternal Plasma DNA in Twin Pregnancies.

Rapid Detection of Chromosomal Aneuploidies by Multiplex Ligation-Dependent Probe Amplification

Noninvasive Prenatal Screening of Fetal Aneuploidy without Massively Parallel Sequencing

Novel Real-Time Pcr Assay for Rapid Prenatal Diagnosis of Down Syndrome: A Prospective Study of 563 Amniocytes

Molecular Cytogenetic Detection of Trisomy 21 in Interphase Nuclei and Metaphase Chromosomes.

Quantitative Real‐time PCR Technique for Rapid Prenatal Diagnosis of Down Syndrome

Prenatal Diagnosis of Down Syndrome Using Cell-Free Fetal DNA in Amniotic Fluid by Quantitative Fluorescent Polymersase Chain Reaction.

[Application of Real-Time Fluorescence Quantitative Polymerase Chain Reaction Techniques for Prenatal Diagnosis of Down Syndrome].

Analysis of NGS-Ministr As A New Detection Strategy Chromosomal Trisomy 16 of Fetal Materials in Miscarriages

Detectionof Fetal Trisomy 8 Mosaicism with Cell-free Fetal DNA in Maternal Plasma

[Rapid Diagnosis of Down's Syndrome by Multiplex Real-Time Fluorescence Relative Quantitative PCR].

Application of Multiplex Ligation-Dependent Probe Amplification for Rapid Detection of Aneuploidies in Prenatal Diagnosis

Rapid detection of 18-trisomy syndrome using primed in situ labeling technique

[Confirmation and analysis of 2 398 positive results of cell-free fetal DNA]

Detection of trisomies 13, 18 and 21 using non-invasive prenatal testing

Prenatal Diagnosis of Trisomy 8 Mosaicism, Initially Identified by Cffdna Screening

Rapid screening for chromosomal aneuploidies using array-MLPA

The Application of NIPT Using Combinatorial Probe-Anchor Synthesis to Identify Sex Chromosomal Aneuploidies (scas) in a Cohort of 570 Pregnancies